Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas-Reference-Cited by-同舟云学术

Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas

Published:2016-06 Issue:6 Volume:69 Page:1055-1061
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Calderaro Julien,Masliah-Planchon Julien,Richer Wilfrid,Maillot Laetitia,Maille Pascale,Mansuy Ludovic,Bastien Claire,de la Taille Alexandre,Boussion Hélène,Charpy Cécile,Jourdain Anne,Bléchet Claire,Pierron Gaelle,Gentien David,Choudat Laurence,Tournigand Christophe,Delattre Olivier,Allory Yves,Bourdeaut Franck

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. Sickle cell disease: renal manifestations and mechanisms;Nath;Nature reviews Nephrology,2015

2. SMARCB1/INI1 inactivation in renal medullary carcinoma;Calderaro;Histopathology,2012

3. Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation;Liu;Am J Surg Pathol,2013

4. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior;Cheng;Mod Pathol,2008

5. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth;Kim;Cancer Genet,2014

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients;European Urology Oncology;2024-07

2. The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates;Cureus;2024-04-17

3. Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors;Expert Review of Clinical Immunology;2024-03-13

4. Molecular testing in gynecologic cancer;Diagnostic Molecular Pathology;2024

5. Prognostic Factors and Models for Non-Metastatic Renal Cell Carcinoma;2024